149 related articles for article (PubMed ID: 36847982)
1. New Insight into the Pharmacological Importance of Atropine as the Potential Inhibitor of AKR1B1 via Detailed Computational Investigations: DFTs, ADMET, Molecular Docking, and Molecular Dynamics Studies.
Ejaz SA; Aziz M; Ahmed A; Alotaibi SS; Albogami SM; Siddique F; Batiha GE
Appl Biochem Biotechnol; 2023 Aug; 195(8):5136-5157. PubMed ID: 36847982
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.
Saeed A; Ejaz SA; Sarfraz M; Tamam N; Siddique F; Riaz N; Qais FA; Chtita S; Iqbal J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807227
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis.
Sarfraz M; Aziz M; Afzal S; Channar PA; Alsfouk BA; Kandhro GA; Hassan S; Sultan A; Hamad A; Arafat M; Qaiser MN; Ahmed A; Siddique F; Ejaz SA
Protein J; 2024 Apr; 43(2):207-224. PubMed ID: 37940790
[TBL] [Abstract][Full Text] [Related]
4. In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization.
Ejaz SA; Saeed A; Birmani PR; Katubi KM; Elqahtani ZM; Al-Buriahi MS; Ujan R; Siddique F; Ahmed SB; Alrowaili ZA
PLoS One; 2022; 17(10):e0271602. PubMed ID: 36301939
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive computational approach for the identification of structure-based potential pharmacological candidates as selective AKR1B1 and AKR1B10 inhibitors: repurposing of purine alkaloids for the treatment of cancer.
Aziz M; Ejaz SA; Tamam N; Siddique F
J Biomol Struct Dyn; 2023; 41(16):7892-7912. PubMed ID: 36214620
[TBL] [Abstract][Full Text] [Related]
6. Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition.
Liu M; Qin X; Li J; Jiang Y; Jiang J; Guo J; Xu H; Wang Y; Bi H; Wang Z
Phys Chem Chem Phys; 2024 Mar; 26(12):9295-9308. PubMed ID: 38469695
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
8. Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.
Amin MR; Yasmin F; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Rajia S; Ogawa Y; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
Glycoconj J; 2022 Apr; 39(2):261-290. PubMed ID: 35037163
[TBL] [Abstract][Full Text] [Related]
9. DFT/TD-DFT calculations, spectroscopic characterizations (FTIR, NMR, UV-vis), molecular docking and enzyme inhibition study of 7-benzoyloxycoumarin.
Alam M; Alam MJ; Azaz S; Parveen M; Park S; Ahmad S
Comput Biol Chem; 2018 Apr; 73():65-78. PubMed ID: 29453141
[TBL] [Abstract][Full Text] [Related]
10. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
[TBL] [Abstract][Full Text] [Related]
11. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
12. Studying the Biological Activity of Trans-[Cu (quin)2(EtOH)2] as Potent Antimicrobial Cu(II) Complex through Computational Investigations: DFT, ADMET and Molecular Docking.
Hussein RK; El-Khayatt AM; Duaij OKA; Alkaoud AM
Front Biosci (Landmark Ed); 2023 Apr; 28(4):84. PubMed ID: 37114549
[TBL] [Abstract][Full Text] [Related]
13. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic profiling, DFT computations, molecular docking and molecular dynamic simulation of biologically active 5-isoquinolinesulfonic acid.
Saral A; Sudha P; Muthu S; Irfan A
J Biomol Struct Dyn; 2023 Feb; 41(2):722-735. PubMed ID: 34882072
[TBL] [Abstract][Full Text] [Related]
15. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.
Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R
Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493
[TBL] [Abstract][Full Text] [Related]
16. Exploring the interactional details between aldose reductase (AKR1B1) and 3-Mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid through molecular dynamics simulations.
Zhan JY; Ma K; Zheng QC; Yang GH; Zhang HX
J Biomol Struct Dyn; 2019 Apr; 37(7):1724-1735. PubMed ID: 29671687
[TBL] [Abstract][Full Text] [Related]
17. Optimization of structures, biochemical properties of ketorolac and its degradation products based on computational studies.
Uzzaman M; Uddin MN
Daru; 2019 Jun; 27(1):71-82. PubMed ID: 30784007
[TBL] [Abstract][Full Text] [Related]
18. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
20. Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency.
Muhammad S; Zahir N; Bibi S; Alshahrani MY; Shafiq-urRehman ; Chaudhry AR; Sarwar F; Tousif MI
Comput Biol Chem; 2024 Apr; 109():108020. PubMed ID: 38286082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
